Andre F. Batista, L. F. (2018). The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease. Wiley-Blackwell.
Chicago Style (17th ed.) CitationAndre F. Batista, Leticia Forny-Germano. The Diabetes Drug Liraglutide Reverses Cognitive Impairment in Mice and Attenuates Insulin Receptor and Synaptic Pathology in a Non-human Primate Model of Alzheimer's Disease. Wiley-Blackwell, 2018.
MLA (9th ed.) CitationAndre F. Batista, Leticia Forny-Germano. The Diabetes Drug Liraglutide Reverses Cognitive Impairment in Mice and Attenuates Insulin Receptor and Synaptic Pathology in a Non-human Primate Model of Alzheimer's Disease. Wiley-Blackwell, 2018.
Warning: These citations may not always be 100% accurate.